Under construction – not a live service
Sign in
Not yet recruitingNo phase

Blood Flow Restriction Training After TIPS Placement in Liver Cirrhosis

Key facts

Who runs it
German Diabetes Center
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
30 people, planned
Starts
2 Jan 2027
Expected to end
31 Dec 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Blood-flow restriction training (BFRT)
Record updated
13 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Diagnosis of liver cirrhosis of any etiology, confirmed by clinical, imaging, or histological criteria
  • Successful TIPS placement for standard clinical indications (e.g., refractory ascites or variceal bleeding)
  • Clinical stability 2-6 weeks after TIPS placement, defined as absence of acute complications requiring hospitalization
  • Child-Pugh class A or B cirrhosis; selected individuals with Child-Pugh C may be included at investigator discretion
  • No evidence of overt hepatic encephalopathy grade ≥ II at screening
  • Ability to ambulate independently (with or without walking aid)
  • Ability to understand study procedures and provide written informed consent
  • Medical clearance by treating hepatologist to participate in moderate physical activity

Who cannot take part

  • Active or recurrent hepatic encephalopathy grade II or higher within 4 weeks prior to screening
  • Acute gastrointestinal bleeding within 14 days prior to enrolment
  • Uncontrolled infection or sepsis
  • Severe cardiopulmonary disease limiting exercise capacity (e.g., NYHA class III-IV heart failure, unstable coronary artery disease, severe pulmonary hypertension)
  • Uncontrolled arterial hypertension (>180/110 mmHg)
  • Severe orthopaedic, neurologic, or musculoskeletal conditions precluding participation in an exercise program
  • Advanced hepatocellular carcinoma or other active malignancy with life expectancy < 6 months
  • Model for End-Stage Liver Disease (MELD) score > 22 at screening
  • Any condition which, in the opinion of the investigator, makes participation unsafe or not in the best interest of the participant
  • Any contra-indication for MRI scanning
  • Current alcohol or substance abuse interfering with study adherence
  • Participation in another interventional clinical trial that may interfere with study outcomes
  • Pregnancy or breastfeeding
  • Regular participation in sports or physical activities for more than 2 hours per week
  • Individuals who do not wish to be informed about unexpected medical findings
  • Non-German-speaking

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to investigate whether a 12-week resistance training with mild blood flow restriction following transjugular intrahepatic portosystemic shunt (TIPS) placement, compared with standard care, leads to improvements in muscle mass and muscle function in individuals with liver cirrhosis. The primary focus is on the functional recovery of skeletal muscle following TIPS rather than solely on morphological changes in muscle mass. In addition, people-reported outcomes, clinical trajectories, and metabolic and inflammatory parameters will be assessed to identify potential predictors of functional response to structured physical activity following TIPS.

The 2 groups in the trial

  • Blood-flow restriction training (BFRT)Treatment being tested

    Resistance training with low loads (30% 1-RM) in combination with a brief occlusion of venous blood flow using a tourniquet while exercising.

  • Control groupNo study treatment, for comparison

    The control group will receive standard care following TIPS placement, including routine clinical follow-up but without training.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Can Blood Flow Restriction Training Counteract Sarcopenia After TIPS in People With Liver Cirrhosis?
Record updated
13 November 2026